BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25618297)

  • 21. Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma.
    Duan S
    Cancer Biomark; 2018 Feb; 21(3):565-574. PubMed ID: 29278874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors.
    Sun B; Qie S; Zhang S; Sun T; Zhao X; Gao S; Ni C; Wang X; Liu Y; Zhang L
    Hum Pathol; 2008 Mar; 39(3):444-51. PubMed ID: 18261629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation between expressions of matrix metalloproteinase-2 & 9 and vasculogenic mimicry in gastrointestinal stromal tumors].
    Qie S; Sun BC; Zhao XL; Zhang SW; Sun T; Gao SY; Wang XH
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(16):1106-9. PubMed ID: 19595140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
    Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma.
    Liu W; Xu G; Ma J; Jia W; Li J; Chen K; Wang W; Hao C; Wang Y; Wang X
    Tohoku J Exp Med; 2011 May; 224(1):29-39. PubMed ID: 21512310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
    Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion.
    Lin H; Huang B; Wang H; Liu X; Hong Y; Qiu S; Zheng J
    Cell Physiol Biochem; 2018; 51(2):991-1000. PubMed ID: 30466107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RCCRT1 is correlated with prognosis and promotes cell migration and invasion in renal cell carcinoma.
    Song S; Wu Z; Wang C; Liu B; Ye X; Chen J; Yang Q; Ye H; Xu B; Wang L
    Urology; 2014 Sep; 84(3):730.e1-7. PubMed ID: 25168566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
    Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
    Sato M; Nakai Y; Nakata W; Yoshida T; Hatano K; Kawashima A; Fujita K; Uemura M; Takayama H; Nonomura N
    PLoS One; 2013; 8(9):e74313. PubMed ID: 24073208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.
    Veliceasa D; Ivanovic M; Hoepfner FT; Thumbikat P; Volpert OV; Smith ND
    FEBS J; 2007 Dec; 274(24):6365-77. PubMed ID: 18021253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
    Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
    Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition.
    Chiablaem K; Lirdprapamongkol K; Keeratichamroen S; Surarit R; Svasti J
    Anticancer Res; 2014 Apr; 34(4):1857-64. PubMed ID: 24692720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
    Aikins AR; Kim M; Raymundo B; Kim CW
    Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation of vasculogenic mimicry with clinicopathologic features and prognosis of ovarian carcinoma].
    Gao Y; Zhao XL; Gu Q; Wang JY; Zhang SW; Zhang DF; Wang XH; Zhao N; Gao YT; Sun BC
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):585-9. PubMed ID: 20079185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of vasculogenic mimicry in human gliomas.
    Liu XM; Zhang QP; Mu YG; Zhang XH; Sai K; Pang JC; Ng HK; Chen ZP
    J Neurooncol; 2011 Nov; 105(2):173-9. PubMed ID: 21533525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival.
    Zhang Y; Li J; Song Y; Chen F; Pei Y; Yao F
    Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
    Huang D; Ding Y; Luo WM; Bender S; Qian CN; Kort E; Zhang ZF; VandenBeldt K; Duesbery NS; Resau JH; Teh BT
    Cancer Res; 2008 Jan; 68(1):81-8. PubMed ID: 18172299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.